

563-556-6292

2442 Meinen Court
Dubuque, IA 52002
FAX: 563-588-6286
Prostate cancer is the most common non-skin cancer diagnosed in men, and the second leading cause of cancer deaths in men, after lung cancer.
The prostate is a gland in the male reproductive system located just below the bladder and in front of the rectum. It is about the size of a walnut and surrounds part of the urethra (the tube that empties urine from the bladder). The prostate gland produces fluid that makes up part of semen.
According to the National Cancer Institute (NCI), almost all prostate cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). Prostate cancer often has no early symptoms. Advanced prostate cancer can cause men to urinate more often or have a weaker flow of urine, but these symptoms can also be caused by benign prostate conditions.
Because of effective screening options for prostate cancer, the disease is often caught before it spreads, and as a whole, survival rates are good for this type of cancer.
The NCI’s Surveillance, Epidemiology, and End Results (SEER) Program estimates that more than 868,300 men in the United States will be diagnosed with prostate cancer and 34,700 men are expected to die of the disease in 2023.
Ovarian cancer encompasses cancers of the ovaries, fallopian tubes, and the primary peritoneum, which is the tissue that lines the abdominal wall and covers the abdominal organs. Taken together, this group is the fifth leading cause of cancer death in women in the United States.
These cancers often go undetected until they’ve reached advanced stages. They may not cause early signs or symptoms, and it is difficult to screen for the disease, according to the National Cancer Institute.
Ovarian cancer is rare – about 1.3 percent of women will be diagnosed with ovarian cancer at some point in their life, according to data from the NCI’s Surveillance, Epidemiology, and End Results Program. An estimated 19,710 women in the United States will be diagnosed with ovarian cancer and 13,270 are expected to die from the disease in 2023.